glp-1 bipolar Exploring Agonists: Adjunct Treatment For Disorder New research links genetic activation
Description
A significant spinal cord injury cut short his career with the FBI
GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the US between 2019 and 2023
"Clinically significant pharmacokinetic drug interactions with benzodiazepines"
Carroll stresses that while these complications are rare, theyre the reason GLP-1 medications require clinician oversight rather than self-administration
